ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Instrumentation

Thermo Fisher buys and plans ahead

by Marc S. Reisch
March 26, 2018 | APPEARED IN VOLUME 96, ISSUE 13

 

Thermo Fisher Scientific has made an acquisition, will shutter a site in the U.K., and plans a pharma services facility in Germany. The acquisition of IntegenX adds a business with technology to rapidly generate forensic DNA profiles of crime suspects. In Ashford, England, Thermo Fisher will end lab-products manufacturing and R&D for plastic lab goods and move operations to facilities in Mexico, China, and Denmark. About 170 jobs are affected, the firm says. And in Rheinfelden, Germany, Thermo Fisher plans to build a $35 million pharma services facility to support customers doing clinical research.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment